
In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …

The September edition of Pharmafocus is now available – click here to read online.

Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis …

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …

Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout …

A research group at the Sahlgrenska Academy at the University of Gothenburg in Sweden have released findings rebutting the claim …

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …

In a shock move, MSD Chairman and Chief Executive Officer Kenneth Frazier (pictured) has announced that he is to resign …

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …